|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Ticlopidine#Structure]] |
| {{Ticlopidine}}
| |
| {{CMG}}; {{AE}} {{AZ}}
| |
|
| |
|
| ==Description==
| | [[Category: Cardiovascular Drugs]] |
| | | [[Category: Drug]] |
| Ticlopidine hydrochloride is a platelet aggregation inhibitor. Chemically it is 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno [3,2-c] pyridine hydrochloride. The structural formula is:
| | [[Category:Antiplatelet drugs]] |
| | |
| {|
| |
| |[[File:Ticlopedine structure.JPG|600px|thumb]]
| |
| |}
| |
| Ticlopidine hydrochloride is a white crystalline solid. It is freely soluble in water and self-buffers to a pH of 3.6. It also dissolves freely in methanol, is sparingly soluble in methylene chloride and ethanol, slightly soluble in acetone and insoluble in a buffer solution of pH 6.3. It has a molecular weight of 300.25.
| |
| | |
| Ticlopidine HCl Tablets, USP for oral administration are provided as white to off-white, oval, unscored, film coated, imprinted tablets containing 250 mg of Ticlopidine Hydrochloride. Each tablet also contains croscarmellose sodium, microcrystalline cellulose and stearic acid as inactive ingredients. The white film coating contains hydroxypropyl methylcellulose, polyethylene glycol and titanium dioxide.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TICLOPIDINE HYDROCHLORIDE TABLET, FILM COATED [APOTEX CORP.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=707127cb-cdcd-81b0-274d-3c11fefa6824 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Drugs]] | |